In this Issue:
Safety of vedolizumab for IBD
Relapse after anti-TNF withdrawal for IBD
Patients’ and gastroenterologists’ perceptions of IBD treatments
Identifying high risk of loss of infliximab response in paediatric CD
Resting energy expenditure in CD
Is CD with orofacial granulomatosis a distinctive subtype?
Hospitalisation for varicella and zoster in children with IBD
Long-term follow-up of ileal pouch anal anastomosis for paediatric UC
FC for predicting postoperative recurrence in paediatric CD
Please login below to download this issue (PDF)